SearchSkip to Search Results
Survival Benefit of Chemotherapy in Oropharyngeal Cancer Patients Treated with Surgery and Post-Operative RadiationDownload
Oropharyngeal squamous cell carcinoma (OPSCC) is the third most common cancer of the head and neck. The incidence of all subtypes of head and neck squamous cell carcinoma has decreased over the past 30 years in Canada and most of the world except for OPSCC. The increasing incidence of OPSCC over...
Head and neck squamous cell carcinoma (HNSCC) is the 6th most prevalent cancer worldwide with rates of human papillomavirus (HPV)-positive oropharyngeal squamous cell carcinoma (OPSCC) dramatically increasing. The overexpression of enhancer of zeste homolog 2 (EZH2), a histone methyltransferase...